Format
Sort by
Items per page

Send to

Choose Destination

Best matches for psychedelics:

Psychedelic Drugs in Biomedicine. Kyzar EJ et al. Trends Pharmacol Sci. (2017)

Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications. Kraehenmann R et al. Curr Neuropharmacol. (2017)

Psychedelics as Medicines: An Emerging New Paradigm. Nichols DE et al. Clin Pharmacol Ther. (2017)

Search results

Items: 1 to 20 of 25537

1.

Association between Drug Use and In-Hospital Outcomes after Infrainguinal Bypass for Peripheral Arterial Occlusive Disease.

Dakour-Aridi H, Arora M, Nejim B, Locham S, Malas MB.

Ann Vasc Surg. 2019 Feb 12. pii: S0890-5096(19)30144-X. doi: 10.1016/j.avsg.2018.12.070. [Epub ahead of print]

PMID:
30769072
2.

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis.

Argento E, Tupper KW, Socias ME.

Int J Drug Policy. 2019 Feb 7;66:80-81. doi: 10.1016/j.drugpo.2018.11.006. [Epub ahead of print]

PMID:
30743091
3.

Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users.

Ona G, Kohek M, Massaguer T, Gomariz A, Jiménez DF, Dos Santos RG, Hallak JEC, Alcázar-Córcoles MÁ, Bouso JC.

J Psychoactive Drugs. 2019 Feb 7:1-11. doi: 10.1080/02791072.2019.1567961. [Epub ahead of print]

PMID:
30732540
4.

A systematic study of microdosing psychedelics.

Polito V, Stevenson RJ.

PLoS One. 2019 Feb 6;14(2):e0211023. doi: 10.1371/journal.pone.0211023. eCollection 2019.

5.

Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.

Martial C, Cassol H, Charland-Verville V, Pallavicini C, Sanz C, Zamberlan F, Vivot RM, Erowid F, Erowid E, Laureys S, Greyson B, Tagliazucchi E.

Conscious Cogn. 2019 Jan 31;69:52-69. doi: 10.1016/j.concog.2019.01.011. [Epub ahead of print]

PMID:
30711788
6.

Binge ethanol and MDMA combination exacerbates HSP27 and Trx-1 (biomarkers of toxic cardiac effects) expression in right ventricle.

Navarro-Zaragoza J, Ros-Simó C, Milanés MV, Valverde O, Laorden ML.

Life Sci. 2019 Mar 1;220:50-57. doi: 10.1016/j.lfs.2019.01.050. Epub 2019 Jan 29.

PMID:
30708098
7.

Two- and three-year follow-up from a gender-specific, web-based drug abuse prevention program for adolescent girls.

Schwinn TM, Schinke SP, Keller B, Hopkins J.

Addict Behav. 2019 Jan 16;93:86-92. doi: 10.1016/j.addbeh.2019.01.010. [Epub ahead of print]

PMID:
30703667
8.

Effective connectivity changes in LSD-induced altered states of consciousness in humans.

Preller KH, Razi A, Zeidman P, Stämpfli P, Friston KJ, Vollenweider FX.

Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2743-2748. doi: 10.1073/pnas.1815129116. Epub 2019 Jan 28.

9.

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.

Sakloth F, Leggett E, Moerke MJ, Townsend EA, Banks ML, Negus SS.

Exp Clin Psychopharmacol. 2019 Jan 10. doi: 10.1037/pha0000253. [Epub ahead of print]

PMID:
30628811
10.

Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.

Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 3;92:109-117. doi: 10.1016/j.pnpbp.2019.01.002. [Epub ahead of print] Review.

PMID:
30611836
11.

Biosynthesis of bioactive natural products from Basidiomycota.

Lin HC, Hewage RT, Lu YC, Chooi YH.

Org Biomol Chem. 2019 Jan 31;17(5):1027-1036. doi: 10.1039/c8ob02774a. Review.

PMID:
30608100
12.

Clinical and Toxicological Profile of NBOMes: A Systematic Review.

Marchi NC, Scherer JN, Fara LS, Remy L, Ornel R, Reis M, Zamboni A, Paim M, Fiorentin TR, Wayhs CAY, Von Diemen L, Pechansky F, Kessler FHP, Limberger RP.

Psychosomatics. 2018 Nov 13. pii: S0033-3182(18)30488-2. doi: 10.1016/j.psym.2018.11.002. [Epub ahead of print] Review.

PMID:
30606495
13.

Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.

Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS.

Psychopharmacology (Berl). 2019 Jan 2. doi: 10.1007/s00213-018-5106-2. [Epub ahead of print]

PMID:
30604183
14.

Prevalence of reagent test-kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City.

Palamar JJ, Barratt MJ.

Drug Alcohol Rev. 2019 Jan;38(1):42-49. doi: 10.1111/dar.12882. Epub 2018 Dec 21.

PMID:
30575155
15.

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.

Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K, Polanco M, Grant R, Griffiths RR.

Front Psychol. 2018 Dec 6;9:2459. doi: 10.3389/fpsyg.2018.02459. eCollection 2018.

16.

DARK classics in chemical neuroscience: atropine, scopolamine and other anticholinergic deliriant hallucinogens.

Lakstygal A, Kolesnikova T, Khatsko S, Zabegalov K, Volgin A, Demin K, Shevyrin V, Wappler-Guzzetta E, Kalueff A.

ACS Chem Neurosci. 2018 Dec 19. doi: 10.1021/acschemneuro.8b00615. [Epub ahead of print]

PMID:
30566832
17.

Tetrahydrocannabinol: a drug of interest.

Tiwari J, Bajpai K, Gupta G, Sharma R, Verma RK, Dua K.

Panminerva Med. 2018 Dec;60(4):228-230. doi: 10.23736/S0031-0808.18.03468-7. No abstract available.

PMID:
30563303
18.

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Johnson MW, Hendricks PS, Barrett FS, Griffiths RR.

Pharmacol Ther. 2018 Dec 4. pii: S0163-7258(18)30215-8. doi: 10.1016/j.pharmthera.2018.11.010. [Epub ahead of print] Review.

PMID:
30521880
19.

The Effects of Substance Abuse on Blood Glucose Parameters in Patients with Diabetes: A Systematic Review and Meta-Analysis.

Ojo O, Wang XH, Ojo OO, Ibe J.

Int J Environ Res Public Health. 2018 Nov 29;15(12). pii: E2691. doi: 10.3390/ijerph15122691. Review.

20.

Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines.

Šuláková A, Fojtíková L, Holubová B, Bártová K, Lapčík O, Kuchař M.

J Pharmacol Toxicol Methods. 2019 Jan - Feb;95:36-46. doi: 10.1016/j.vascn.2018.11.001. Epub 2018 Nov 24.

PMID:
30481558

Supplemental Content

Loading ...
Support Center